These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31890426)

  • 1. Helicobacter pylori is Associated with Less Fistulizing, Stricturing, and Active Colitis in Crohn's Disease Patients.
    Fialho A; Fialho A; Nassri A; Muenyi V; Malespin M; Shen B; De Melo SW
    Cureus; 2019 Nov; 11(11):e6226. PubMed ID: 31890426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients With Stricturing or Penetrating Crohn's Disease Phenotypes Report High Disease Burden and Treatment Needs.
    Fan Y; Zhang L; Omidakhsh N; Bohn RL; Thompson JS; Brodovicz KG; Deepak P
    Inflamm Bowel Dis; 2023 Jun; 29(6):914-922. PubMed ID: 35880838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are perineal and luminal fistulas associated in Crohn's disease? A population-based study.
    Tang LY; Rawsthorne P; Bernstein CN
    Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1130-4. PubMed ID: 16905369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tobacco consumption and disease duration are associated with fistulizing and stricturing behaviors in the first 8 years of Crohn's disease.
    Picco MF; Bayless TM
    Am J Gastroenterol; 2003 Feb; 98(2):363-8. PubMed ID: 12591056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stricturing and Fistulizing Crohn's Disease Is Associated with Anti-tumor Necrosis Factor-Induced Psoriasis in Patients with Inflammatory Bowel Disease.
    Weizman AV; Sharma R; Afzal NM; Xu W; Walsh S; Stempak JM; Nguyen GC; Croitoru K; Steinhart AH; Silverberg MS
    Dig Dis Sci; 2018 Sep; 63(9):2430-2438. PubMed ID: 29736839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The analysis of clinico-pathologic characteristics in patients who underwent surgery due to stricturing and non-perineal fistulizing forms of Crohn's disease: a retrospective cohort study.
    Cayci M; Bostanci EB; Turhan N; Karaman K; Dalgic T; Ozer I; Ercan M; Ulas M; Akoglu M
    Int J Surg; 2015 Mar; 15():49-54. PubMed ID: 25647540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inverse association between Helicobacter pylori and inflammatory bowel disease: myth or fact?
    Kayali S; Gaiani F; Manfredi M; Minelli R; Nervi G; Nouvenne A; Leandro G; Di Mario F; De' Angelis GL
    Acta Biomed; 2018 Dec; 89(9-S):81-86. PubMed ID: 30561399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between Helicobacter pylori infection and Crohn's disease: a meta-analysis.
    Wang WL; Xu XJ
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10509-10516. PubMed ID: 31841206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of Helicobacter pylori gastritis in newly diagnosed children with inflammatory bowel disease.
    Roka K; Roubani A; Stefanaki K; Panayotou I; Roma E; Chouliaras G
    Helicobacter; 2014 Oct; 19(5):400-5. PubMed ID: 24827117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of inflammatory bowel disease among an indigent multi-ethnic population in the United States.
    Malaty HM; Hou JK; Thirumurthi S
    Clin Exp Gastroenterol; 2010; 3():165-70. PubMed ID: 21694862
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Lucero Y; Oyarzún A; O'Ryan M; Quera R; Espinosa N; Valenzuela R; Simian D; Alcalde E; Arce C; Farfán MJ; Vergara AF; Gajardo I; Mendez J; Carrasco J; Errázuriz G; Gonzalez M; Ossa JC; Maiza E; Perez-Bravo F; Castro M; Araya M
    Front Cell Infect Microbiol; 2017; 7():376. PubMed ID: 28879170
    [No Abstract]   [Full Text] [Related]  

  • 12. Fistulizing pattern in Crohn's disease and pancolitis in ulcerative colitis are independent risk factors for cancer: a single-center cohort study.
    Biancone L; Zuzzi S; Ranieri M; Petruzziello C; Calabrese E; Onali S; Ascolani M; Zorzi F; Condino G; Iacobelli S; Pallone F
    J Crohns Colitis; 2012 Jun; 6(5):578-87. PubMed ID: 22398047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The low prevalence of Helicobacter pylori gastritis in newly diagnosed inflammatory bowel disease children and adolescent].
    Sładek M; Jedynak-Wasowicz U; Wedrychowicz A; Kowalska-Duplaga K; Pieczarkowski S; Fyderek K
    Przegl Lek; 2007; 64 Suppl 3():65-7. PubMed ID: 18431918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter pylori prevalence and clinical significance in patients with quiescent Crohn's disease.
    Lahat A; Kopylov U; Neuman S; Levhar N; Yablecovitch D; Avidan B; Weiss B; Ben-Horin S; Eliakim R;
    BMC Gastroenterol; 2017 Feb; 17(1):27. PubMed ID: 28193167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Incidence of Recurrent Crohn's Disease Following Colectomy for Ulcerative Colitis Revealed with Long Follow-Up.
    Shamah S; Schneider J; Korelitz BI
    Dig Dis Sci; 2018 Feb; 63(2):446-451. PubMed ID: 29282640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Helicobacter pylori infection and related upper gastrointestinal lesions in patients with inflammatory bowel diseases. A cross-sectional study with matching.
    Parente F; Molteni P; Bollani S; Maconi G; Vago L; Duca PG; Rembacken B; Axon AT; Bianchi Porro G
    Scand J Gastroenterol; 1997 Nov; 32(11):1140-6. PubMed ID: 9399396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the prevalence of infection with Helicobacter pylori in patients with inflammatory bowel disease.
    Pearce CB; Duncan HD; Timmis L; Green JR
    Eur J Gastroenterol Hepatol; 2000 Apr; 12(4):439-43. PubMed ID: 10783998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible protective effect of 5-aminosalicylic acid on Helicobacter pylori infection in patients with inflammatory bowel disease.
    Piodi LP; Bardella M; Rocchia C; Cesana BM; Baldassarri A; Quatrini M
    J Clin Gastroenterol; 2003 Jan; 36(1):22-5. PubMed ID: 12488702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour necrosis factor (TNF) gene polymorphism in Crohn's disease (CD): influence on disease behaviour?
    Louis E; Peeters M; Franchimont D; Seidel L; Fontaine F; Demolin G; Croes F; Dupont P; Davin L; Omri S; Rutgeerts P; Belaiche J
    Clin Exp Immunol; 2000 Jan; 119(1):64-8. PubMed ID: 10606965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Possible pathogenic role of vascular, immunologic and genetic factors in certain gastroenterologic disorders].
    Papp M
    Orv Hetil; 2008 Nov; 149(48):2269-76. PubMed ID: 19028649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.